tiprankstipranks
Palisade Bio CEO Finley’s Revised Employment and Compensation Deal
Company Announcements

Palisade Bio CEO Finley’s Revised Employment and Compensation Deal

Don't Miss our Black Friday Offers:

Palisade Bio ( (PALI) ) has provided an update.

Palisade Bio, Inc. has entered into a revised employment agreement with its CEO and CFO, J.D. Finley, maintaining his annual $542,000 salary and eligibility for a 50% target bonus and stock options. If terminated without cause or if he resigns for good reason, Finley could receive up to 18 months of salary and COBRA benefits, especially during a change in company control. Additionally, his equity awards could fully vest, subject to signing a release of claims. Finley also has agreements concerning confidentiality, inventions, and indemnification with the company.

See more data about PALI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPalisade Bio to present preclinical results for PALI-2108
TheFlyPalisade Bio initiated with a Buy at Brookline
TheFlyPalisade Bio price target lowered to $8 from $22.50 at Maxim
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App